SCI Q1 2026 Earnings Transcript

Service International reported Q1 adjusted EPS of $0.97, up slightly from $0.96, as stronger cemetery results and a lower share count offset a $17 million decline in comparable funeral revenue and a $23 million drop in funeral gross profit. Funeral volumes fell 6.6%, pushing funeral gross margin down 300 bps to just over 21%, while comparable cemetery revenue rose 7% and preneed cemetery sales production increased 10%. Management reaffirmed full-year 2026 EPS guidance of $4.05-$4.35 and cash flow guidance of $1.0B-$1.06B, but flagged that weaker funeral volumes could keep results toward the lower half of the range.

Analysis

The key signal is not the headline EPS print; it is the widening spread between volatile mortality-driven revenue and increasingly self-helpable cemetery/preneed economics. That mix makes SCI look more like a cash-generative asset manager on a lagged liability stream than a pure same-store death-volume story: weaker near-term funeral volumes hit incremental margins hard, but preneed and trust income are compounding visibility into future revenue while buybacks continue to shrink the float. The market is likely underappreciating how much of the year’s earnings variability is now a timing issue, not a demand destruction issue.

The second-order effect is competitive: weaker volumes disproportionately pressure smaller private operators with less scale, less access to capital, and poorer marketing infrastructure, while SCI can keep investing in seminars, lead generation, digital, and cemetery development through the trough. That should accelerate share gains in preneed and M&A over the next 6-12 months because distressed independents may find it harder to refinance or justify maintenance capex as fixed cemetery costs rise faster than inflation. In other words, soft funeral volumes may be a near-term P&L drag but a medium-term consolidation catalyst.

The real risk is that management’s historical seasonality framework proves too optimistic if mortality trends remain weak into Q2/Q3; then the market will force the stock to trade on the lower half of guidance and on a weaker margin bridge. Another risk is trust return normalization: a rebound in April helps sentiment, but the annual earnings contribution is still market-dependent and could easily wobble if equities give back gains. The counterpoint is that the stock’s de-risking mechanism is strong: aggressive repurchases at roughly $80 and a sub-4x leverage profile create downside support, while any rebound in volumes produces outsized operating leverage into the back half of the year.

Key Decisions for Investors

• Long SCI vs. short a smaller funeral/cemetery operator basket over the next 3-6 months: thesis is that scale and marketing spend will widen share gaps while fixed-cost pressure hits subscale peers first. Risk/reward favors the pair if mortality stays soft and capital markets remain tight.
• Add to SCI on any post-earnings pullback toward the low end of the guided range; use a 6-9 month horizon. Upside comes from volume normalization plus buyback support, while downside is cushioned by recurring cash flow and ongoing repurchases.
• Consider SCI Jan-2027 call spreads to express a second-half/2026 normalization view. The setup is asymmetric if volumes merely revert toward historical seasonal patterns, but theta risk is meaningful if Q2 does not improve.
• Avoid chasing after strong days; wait for either a failed bounce or evidence that funeral comps are still negative in early Q2. If April mortality data remains weak, expect another de-rate and better entry.
• If you want a relative-value hedge, pair long SCI with short a high-multiple consumer discretionary name to capture the rotation into cash-yielding, capital-returning defensives.